Loading...

Christina Chambers

Title(s)Professor , Pediatrics
SchoolHealth Sciences
Address9500 Gilman Drive #0828
La Jolla CA 92093
Phone858-246-1704
ORCID ORCID Icon0000-0003-4675-7722 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Diego and San Diego State UniversityPhDPublic Health Epidemiology
    San Diego State University, San DiegoMPHEpidemiology
    California State University, FullertonBAAnthropology
    Collapse Awards and Honors
    Health Sciences, University of California, San DiegoNational Center of Leadership in Academic Medicine Mentor Honor, Junior Faculty Development Program
    San Diego Business Journal16th Annual Women Who Mean Business Awards
    Teratology Society F. Clarke Fraser New Investigator Award
    University of California, San DiegoEpidemiology and Biostatistics Exchange Abstract and Presentation Award
    Rady Children’s Hospital Rady Children’s Hospital Award for Excellence in Research
    Teratology SocietyTeratology Society Patricia Rodier Mid-Career Award in Research and Mentoring
    Teratology SocietyThomas H. Shephard Award Teratology
    University of California, San DiegoChancellor’s Award for Excellence in Postdoctoral Scholar Mentoring

    Collapse Overview 
    Collapse Overview
    Dr. Chambers is a professor of pediatrics at University of California, San Diego and Vice Chair of Clinical Research for the Department of Pediatrics at UCSD and Rady Children's Hospital. She is a perinatal epidemiologist, whose research is focused on environmental exposures and pregnancy and child health outcomes, including birth defects. She co-directs the Center for Better Beginnings in the Department of Pediatrics at UCSD and is the Program Director of MotherToBabyCalifornia - a service providing evidence-based information on exposures during pregnancy and lactation to the public and health care providers. She is the founder and Program Director of Mommy’s Milk, a nationwide human milk biorepository for research. Furthermore, she is the director of the UCSD ACTRI Center for Life Course and Vulnerable Populations Research, which brings together a unique multidisciplinary group of researchers to address study questions across the lifespan and special populations.

    Dr. Chambers leads a number of national and international complex longitudinal cohort studies and clinical trials of prenatal exposures and child health and development. Her research over the last 20 years has focused on environmental causes of birth defects, other adverse pregnancy outcomes and childhood disabilities, with a focus on pre- and postnatal exposure to recreational substances and medications. Her research has been instrumental in identifying previously unrecognized human teratogens, as well as ruling out substantial risk for other prenatal exposures.

    Collapse Research 
    Collapse Research Activities and Funding
    Home vs. Clinic Collection of Human Milk in Evaluating the Pharmacokinetics of Four Medications
    NIH/NICHD R21HD104412Nov 15, 2020 - Oct 31, 2022
    Role: Principal Investigator
    Evaluating the Effects of COVID-19 Infection in Pregnancy and Lactation
    UC Office of the President R00RG2372Apr 21, 2020 - Oct 21, 2020
    Role: Principal Investigator
    Genomic and Environmental Determinants of Infant Deaths in San Diego County in 2015-2022
    NIH/NICHD R01HD101540Apr 1, 2020 - Jan 31, 2025
    Role: Co-Principal Investigator
    Reassessing FASD: Novel Approaches for Evaluating Exposure, Diagnosis and Outcomes in Children Prenatally Exposed to Alcohol
    NIH/NIAAA R01AA027785Apr 1, 2020 - Mar 31, 2023
    Role: Co-Investigator
    Role Description: Using data from the NIH funded Collaboration to Establish the Prevalence and Characteristics of FASD in U.S. Communities (CoFASP), this study aims to examine the characterizations of prenatal alcohol exposure and diagnosis of fetal alcohol spectrum disorders.
    4/6 Planning for the HEALthy Early Development Study
    NIH/NIDA R34DA050341Sep 1, 2019 - Mar 31, 2021
    Role: Principal Investigator
    The Safety of Asthma Medications During Pregnancy and Lactation: Evidence Gaps and How to Fill Them
    NIH/NHLBI R13HL149440Sep 1, 2019 - Aug 31, 2020
    Role: Principal Investigator
    Detection of Marijuana Metabolites in Breast Milk and Relation to Child Neurodevelopmental Outcomes
    The Gerber Foundation 6488Jun 25, 2019 - Jun 24, 2022
    Role: Co-Principal Investigator
    Prucalopride Pregnancy Exposure Study: a VAMPSS post-marketing surveillance study of Prucalopride safety in pregnancy
    Takeda Pharmaceutical 20193538Jun 1, 2019 - Jun 30, 2025
    Role: Principal Investigator
    Role Description: The main goal of this project is to evaluate the maternal and fetal risks associated with the use of Prucalopride during pregnancy.
    Sleep in Children with Fetal Alcohol Spectrum Disorders
    NIH R21AA026697May 1, 2019 - Apr 1, 2021
    Role: Subaward PI
    California Birth Defects Monitoring Program
    California Department of Public Health 18-0665Apr 1, 2019 - Jun 30, 2022
    Role: Principal Investigator
    A Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated with Tildrakizumab
    Sun Pharma Global FZE 20194611Mar 15, 2019 - Sep 14, 2027
    Role: Principal Investigator
    Role Description: The main goal of this project is to evaluate the maternal and fetal risks associated with the use of Tildrakizumab during pregnancy.
    Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
    NICHD HHSN-275201000003IOct 30, 2018 - Sep 21, 2020
    Role: Sub award PI
    Child Development Resource Center, A Model of Collaborative, Culturally Congruent, Family-focused Care
    NIH/NIAAA S06GM128073Oct 1, 2018 - Jul 31, 2022
    Role: Co-Investigator
    Role Description: This study will test a culturally congruent collaborative care framework among American Indian reservation based families in San Diego County to decrease barriers to care, to decrease stress, depression, and mental – health issues among both children with developmental disabilities and their caregivers, and to improve specific child outcomes.
    International Collaboration to Develop Scalable Methods for Early Detection of Neurodevelopmental Disorder Due to Prenatal Alcohol Exposure
    NIH/NIAAA R01AA026579Sep 1, 2018 - Jun 30, 2023
    Role: Principal Investigator
    Early Predictors of FASD in Ukraine (Supplement)
    NIH/NIAAA 3U01AA014835-S1Sep 1, 2018 - May 31, 2021
    Role: Principal Investigator
    Role Description: The purpose of this award is to support efforts to build on the existing aims of this longitudinal cohort study in Ukraine, which are focused on earlier identification of children affected by prenatal alcohol exposure, by addressing the potentially important confounder of comorbidity with HIV infection in pregnant women.
    Discovery of Genetic Basis of Fetal Alcohol Spectrum Disorders
    NIH/NHLBI/NIAAA 1X01 HL145702-01Sep 1, 2018 - Dec 31, 2020
    Role: Principal Investigator
    Role Description: The main goal of this study is to examine the role of genetic susceptibility for FASD using mother-child paired biological samples previously collected as part of an NIH funded cohort study in Ukraine.
    San Diego Study of Outcomes in Mothers and Infants (the "SOMI Study”)
    Rady Children’s Inst. for Genomic Medicine MOUMay 1, 2018 - Dec 31, 2020
    Role: Principal Investigator
    Role Description: The San Diego Study of Outcomes in Mother and Infants (SOMI) will examine a generation's worth of San Diego births ("'2000-2019) to understand relationships between genomic and epigenomic prenatal and postnatal factors and pediatric health outcomes.
    Benralizumab Pregnancy Exposure Study: a VAMPSS postmarketing surveillance study of Benralizumab safety in pregnancy
    Astrazeneca 20173256Dec 20, 2017 - Dec 20, 2024
    Role: Principal Investigator
    Role Description: The main goal of this project is to evaluate the maternal and fetal risks associated with the use of Benralizumab during pregnancy.
    Regeneron Pharmaceuticals, Dupilumab Pregnancy Exposure Registry
    Regeneron 20172136Sep 27, 2017 - Aug 26, 2027
    Role: Principal Investigator
    Role Description: The main goal of this project is to evaluate the maternal and fetal risks associated with the use of Dupilumab during pregnancy.
    Detection of Marijuana Metabolites in Human Milk
    Gerber Foundation 4998May 18, 2017 - Dec 31, 2020
    Role: Co-Principal Investigator
    Role Description: The main goal of this project is to utilize a recently developed valid quantitative assay for cannabinoids (THC, cannabidiol, and cannabinol) to measure the level of exposure to the infant through human milk. We will examine the quantitative assay results relative to maternal report of the timing, frequency and dose of marijuana use preceding the milk collection. Additionally, we will examine selected infant health-related outcomes associated with various levels of cannabinoid exposure via human milk.
    Sarilumab Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Study
    Sanofi-Aventis 20172956Jan 1, 2017 - Jan 1, 2027
    Role: Principal Investigator
    Role Description: The main goal of this project is to evaluate the maternal and fetal risks associated with the use of sarilumab during pregnancy.
    Development of Protocol for Repatha® (evolocumab) Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Study
    Amgen 2179627Oct 3, 2016 - Oct 2, 2021
    Role: Principal Investigator
    Role Description: The main goal of this project is to evaluate the maternal and fetal risks associated with the use of Repatha during pregnancy
    The Mepolizumab Pregnancy Exposure Study: a VAMPSS post marketing surveillance study of Mepolizumab safety in pregnancy
    GlaxoSmithKline LLC. 20164835Sep 14, 2016 - Jul 31, 2022
    Role: Principal Investigator
    Role Description: The main goal of this project is to evaluate the maternal and fetal risks associated with the use of Mepolizumab during pregnancy.
    Vedolizumab Pregnancy Exposure Registry: an OTIS Autoimmune Diseases in Pregnancy Project
    Takeda 20152059Nov 5, 2015 - Nov 4, 2020
    Role: Principal Investigator
    Role Description: The main goal of the study is to monitor planned and unplanned pregnancies exposed to vedolizumab and to evaluate the possible teratogenic effect of this medication relative to specified pregnancy outcomes, and to evaluate potential effects of prenatal vedolizumab exposure on infant health through one year of age compared to children born to mothers with ulcerative colitis and/or Crohn’s disease who did not use vedolizumab during pregnancy, and children born to mothers without an autoimmune disease.
    San Diego Clinical and Translational Research Institute (CTRI)
    NIH/NCATS 5UL1TR0001442-04Aug 31, 2015 - Apr 30, 2025
    Role: Co-Investigator
    Collaboration to Establish the Prevalence of FASD in San Diego, CA
    NIH/NIAAA U01AA019879Jul 1, 2015 - Aug 31, 2018
    Role: Principal Investigator
    Apremilast Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Project
    Celgene 20143739Sep 25, 2014 - Dec 31, 2023
    Role: Principal Investigator
    Role Description: The main goal of the study is to monitor planned and unplanned pregnancies exposed to apremilast and to evaluate the possible teratogenic effect of this medication relative to specified pregnancy outcomes, and to evaluate potential effects of prenatal apremilast exposure on infant health through one year of age.
    Tofacitinib Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
    Pfizer 20131407Jun 17, 2013 - Jul 31, 2025
    Role: Principal Investigator
    Role Description: The main goal of the Tofacitinib Pregnancy Exposure Registry is to follow pregnant women with or without rheumatoid arthritis who have or have not been treated with tofacitinib during pregnancy to evaluate the possible effect of this disease, and or this medication on the pregnancy outcome including child development and growth up to one year of age.
    Stelara® Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Project
    Janssen Biotech Inc. 20132318Jun 1, 2013 - Dec 31, 2025
    Role: Principal Investigator
    Role Description: The specific aim of this study is to monitor planned and unplanned pregnancies exposed to Stelara® (ustekinumab), to evaluate whether there are any teratogenic effects of this medication in pregnancy outcomes, and to evaluate potential effects of prenatal use of Stelara® exposure on infant health status through one year of age.
    Influence of nutrition on growth and neurodevelopment in children with FASD
    NIH/NIAAA R01AA021551Sep 10, 2012 - Jun 30, 2017
    Role: Principal Investigator
    Cimzia® Pregnancy Exposure Registry – an OTIS Autoimmune Diseases in Pregnancy Project
    UCB Pharma, Inc. 20113868Feb 13, 2012 - May 12, 2022
    Role: Principal Investigator
    Role Description: The purpose of the OTIS Autoimmune Diseases in Pregnancy Project, Cimzia® Pregnancy Exposure Registry is to follow pregnant women with or without rheumatoid arthritis or Crohn’s Disease who have or have not been treated with Cimzia® during pregnancy to evaluate the possible effect of these diseases, and or this medication on the pregnancy outcome including child development and growth up to five years of age.
    The Teriflunomide Pregnancy Exposure Registry – an OTIS Autoimmune Diseases in Pregnancy Project
    Genzyme(Sanofi-Aventis) 20113565Oct 25, 2011 - Oct 1, 2022
    Role: Principal Investigator
    Role Description: The main goal of this project is to evaluate the fetal risk associated with the use of a new multiple sclerosis drug during pregnancy.
    OTIS Autoimmune Diseases in Pregnancy Project: the Actemra® Pregnancy Registry
    Hoffman La Roche 20090812Nov 1, 2010 - Dec 31, 2020
    Role: Principal Investigator
    Role Description: The main goal for this project is to evaluate the fetal risk associated with the use of Actemra® for RA in pregnancy.
    Pregnancy outcomes and asthma medications in pregnancy: a Demonstration Project
    AHRQ R18HS018474Sep 30, 2009 - Jul 31, 2014
    Role: Principal Investigator
    Early Predictors of FASD in Ukraine
    NIH/NIAAA 5U01AA014835Sep 30, 2003 - May 31, 2022
    Role: Principal Investigator
    Role Description: The major goal of this study is to develop a panel of biomarker tests along with a clinical prediction tool that can help improve our ability to identify children with FASD in infancy so they can obtain optimum benefit from early intervention.
    Dysmorphology Research Resource
    NIH/NIAAA 5U24AA014815Sep 30, 2003 - May 31, 2022
    Role: Co-Investigator
    Role Description: The major goal of this project is to use telemedicine and face-to-face examinations to identify children affected by prenatal alcohol exposure in all consortium sites, including remote, medically underserved areas in Minnesota and New Mexico, and to provide these individuals with access to affective intervention programs.
    General Clinical Research Center
    NIH/NCRR M01RR000827Jan 27, 1997 - Nov 30, 2010
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women. JAMA. 2020 10 06; 324(13):1347-1348. Chambers C, Krogstad P, Bertrand K, Contreras D, Tobin NH, Bode L, Aldrovandi G. PMID: 32822495.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsPHPublic Health
    2. Association between fetal sex and maternal plasma microRNA responses to prenatal alcohol exposure: evidence from a birth outcome-stratified cohort. Biol Sex Differ. 2020 Sep 10; 11(1):51. Salem NA, Mahnke AH, Wells AB, Tseng AM, Yevtushok L, Zymak-Zakutnya N, Wertlecki W, Chambers CD, Miranda RC. PMID: 32912312.
      View in: PubMed   Mentions:    Fields:    
    3. Patterns of Prenatal Alcohol Exposure and Alcohol-Related Dysmorphic Features. Alcohol Clin Exp Res. 2020 Aug 09. Bandoli G, Jones K, Wertelecki W, Yevtushok L, Zymak-Zakutnya N, Granovska I, Plotka L, Chambers C. PMID: 32772389.
      View in: PubMed   Mentions:    Fields:    
    4. Update on the developmental consequences of cannabis use during pregnancy and lactation. Birth Defects Res. 2020 Sep; 112(15):1126-1138. Grant KS, Conover E, Chambers CD. PMID: 32770666.
      View in: PubMed   Mentions:    Fields:    
    5. Characterizing Alcohol-Related Neurodevelopmental Disorder: Prenatal Alcohol Exposure and the Spectrum of Outcomes. Alcohol Clin Exp Res. 2020 06; 44(6):1245-1260. Coles CD, Kalberg W, Kable JA, Tabachnick B, May PA, Chambers CD. PMID: 32173870.
      View in: PubMed   Mentions:    Fields:    
    6. Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years. Mult Scler Relat Disord. 2020 Aug; 43:102146. Oh J, Achiron A, Celius EG, Chambers C, Derwenskus J, Devonshire V, Hellwig K, Hutton GJ, McCombe P, Moore M, Rog D, Schneider JR, Simm RF, Sousa L, Vincent SG, Chung L, Daizadeh N, Mitchell C, Compston DAS. PMID: 32498033.
      View in: PubMed   Mentions:    Fields:    
    7. Environmental and Socioeconomic Factors Influence the Live-Born Incidence of Congenital Heart Disease: A Population-Based Study in California. J Am Heart Assoc. 2020 Apr 21; 9(8):e015255. Peyvandi S, Baer RJ, Chambers CD, Norton ME, Rajagopal S, Ryckman KK, Moon-Grady A, Jelliffe-Pawlowski LL, Steurer MA. PMID: 32306820.
      View in: PubMed   Mentions: 2     Fields:    
    8. Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage. Paediatr Perinat Epidemiol. 2020 09; 34(5):597-606. Palmsten K, Chambers CD, Wells A, Bandoli G. PMID: 32207549.
      View in: PubMed   Mentions:    Fields:    
    9. Clinicians' Perspective of the New Pregnancy and Lactation Labeling Rule (PLLR): Results from an AAAAI/FDA Survey. J Allergy Clin Immunol Pract. 2020 Jun; 8(6):1947-1952. Namazy J, Chambers C, Sahin L, Johnson T, Dinatale M, Lappin B, Schatz M. PMID: 32084595.
      View in: PubMed   Mentions: 1     Fields:    
    10. Cohort study of respiratory hospital admissions, air quality and sociodemographic factors in preterm infants born in California. Paediatr Perinat Epidemiol. 2020 03; 34(2):130-138. Steurer MA, Costello J, Baer RJ, Oltman SP, Feuer SK, Pacheco-Werner T, Rogers E, Jankowska MM, Block J, McCarthy M, Pantell MS, Chambers C, Ryckman KK, Jelliffe-Pawlowski LL. PMID: 32026503.
      View in: PubMed   Mentions:    Fields:    
    11. Psychological distress in pregnancy and postpartum. Women Birth. 2020 Nov; 33(6):583-591. Obrochta CA, Chambers C, Bandoli G. PMID: 32035798.
      View in: PubMed   Mentions:    Fields:    
    12. Health Advantages and Disparities in Preterm Birth Among Immigrants Despite Disparate Sociodemographic, Behavioral, and Maternal Risk Factors in San Diego, California. Matern Child Health J. 2020 Feb; 24(2):153-164. Araneta MRG, Baer RJ, Muglia LJ, Ryckman KK, Ryu J, Sidelinger DE, Jeliffe-Powlowski LL, Chambers CD. PMID: 31838667.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Immune network dysregulation associated with child neurodevelopmental delay: modulatory role of prenatal alcohol exposure. J Neuroinflammation. 2020 Jan 28; 17(1):39. Bodnar TS, Raineki C, Wertelecki W, Yevtushok L, Plotka L, Granovska I, Zymak-Zakutnya N, Pashtepa A, Wells A, Honerkamp-Smith G, Coles CD, Kable JA, Chambers CD, Weinberg J. PMID: 31992316.
      View in: PubMed   Mentions:    Fields:    
    14. Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease? J Am Heart Assoc. 2019 11 19; 8(22):e013194. Steurer MA, Peyvandi S, Baer RJ, Oltman SP, Chambers CD, Norton ME, Ryckman KK, Moon-Grady AJ, Keller RL, Shiboski SC, Jelliffe-Pawlowski LL. PMID: 31726960.
      View in: PubMed   Mentions:    Fields:    
    15. Acetaminophen use in pregnancy: Examining prevalence, timing, and indication of use in a prospective birth cohort. Paediatr Perinat Epidemiol. 2020 05; 34(3):237-246. Bandoli G, Palmsten K, Chambers C. PMID: 31696962.
      View in: PubMed   Mentions: 1     Fields:    
    16. Fetal Alcohol Spectrum Disorders in a Pacific Southwest City: Maternal and Child Characteristics. Alcohol Clin Exp Res. 2019 12; 43(12):2578-2590. Chambers CD, Coles C, Kable J, Akshoomoff N, Xu R, Zellner JA, Honerkamp-Smith G, Manning MA, Adam MP, Jones KL. PMID: 31688971.
      View in: PubMed   Mentions: 1     Fields:    
    17. Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study. PLoS One. 2019; 14(10):e0223603. Chambers CD, Johnson DL, Xu R, Luo Y, Lopez-Jimenez J, Adam MP, Braddock SR, Robinson LK, Vaux K, Lyons Jones K. PMID: 31626646.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    18. Organic contaminants in human breast milk identified by non-targeted analysis. Chemosphere. 2020 Jan; 238:124677. Tran CD, Dodder NG, Quintana PJE, Watanabe K, Kim JH, Hovell MF, Chambers CD, Hoh E. PMID: 31524616.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    19. Oseltamivir use in pregnancy: Risk of birth defects, preterm delivery, and small for gestational age infants. Birth Defects Res. 2019 11 15; 111(19):1487-1493. Chambers CD, Johnson D, Xu R, Luo Y, Jones KL. PMID: 31397112.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    20. An Online Geographic Data Visualization Tool to Relate Preterm Births to Environmental Factors. Prev Chronic Dis. 2019 08 08; 16:E102. Jankowska MM, Yang JA, Block J, Baer RJ, Jelliffe-Pawlowski LL, Flores S, Pacheco-Warner T, Costantino A, Fuchs J, Chambers CD, Newel G. PMID: 31400100.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    21. Persistent Changes in Stress-Regulatory Genes in Pregnant Women or Children Exposed Prenatally to Alcohol. Alcohol Clin Exp Res. 2019 09; 43(9):1887-1897. Sarkar DK, Gangisetty O, Wozniak JR, Eckerle JK, Georgieff MK, Foroud TM, Wetherill L, Wertelecki W, Chambers CD, Riley E, Zymak-Zakutnya N, Yevtushok L. PMID: 31329297.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    22. Fetal alcohol spectrum disorders: Mechanisms, diagnosis, treatment, and prevention. Birth Defects Res. 2019 07 15; 111(12):683-685. Parnell SE, Chambers CD. PMID: 31334923.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Factors Associated With Preterm Delivery Among Women With Rheumatoid Arthritis and Women With Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2019 08; 71(8):1019-1027. Smith CJF, Förger F, Bandoli G, Chambers CD. PMID: 30133181.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. Forty Years of Assessing Neurodevelopmental and Behavioral Effects of Prenatal Alcohol Exposure in Infants: What Have We Learned? Alcohol Clin Exp Res. 2019 08; 43(8):1632-1642. Garrison L, Morley S, Chambers CD, Bakhireva LN. PMID: 31206743.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Impact of antidepressant use, discontinuation, and dosage modification on maternal depression during pregnancy. Eur Neuropsychopharmacol. 2019 07; 29(7):803-812. Bérard A, Sheehy O, Zhao JP, Chambers C, Roth M, Bozzo P, Johnson D, Kao K, Lavigne S, Wolfe L, Quinn D, Dieter K. PMID: 31248651.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. The Prevalence of Fetal Alcohol Spectrum Disorders in An American Indian Community. Int J Environ Res Public Health. 2019 06 20; 16(12). Montag AC, Romero R, Jensen T, Goodblanket A, Admire A, Whitten C, Calac D, Akshoomoff N, Sanchez M, Zacarias M, Zellner JA, Del Campo M, Jones KL, Chambers CD. PMID: 31226736.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience. Mult Scler. 2020 06; 26(7):829-836. Vukusic S, Coyle PK, Jurgensen S, Truffinet P, Benamor M, Afsar S, Purvis A, Poole EM, Chambers C. PMID: 30968734.
      View in: PubMed   Mentions: 2     Fields:    
    28. Maternal circulating miRNAs that predict infant FASD outcomes influence placental maturation. Life Sci Alliance. 2019 04; 2(2). Tseng AM, Mahnke AH, Wells AB, Salem NA, Allan AM, Roberts VH, Newman N, Walter NA, Kroenke CD, Grant KA, Akison LK, Moritz KM, Chambers CD, Miranda RC. PMID: 30833415.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    29. Maternal dyslipidemia and risk for preterm birth. PLoS One. 2018; 13(12):e0209579. Smith CJ, Baer RJ, Oltman SP, Breheny PJ, Bao W, Robinson JG, Dagle JM, Liang L, Feuer SK, Chambers CD, Jelliffe-Pawlowski LL, Ryckman KK. PMID: 30576377.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Risk of preterm and early term birth by maternal drug use. J Perinatol. 2019 02; 39(2):286-294. Baer RJ, Chambers CD, Ryckman KK, Oltman SP, Rand L, Jelliffe-Pawlowski LL. PMID: 30573752.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. High risk of spontaneous preterm birth among infants with gastroschisis. . 2019 01; 179(1):37-42. Baer RJ, Chambers CD, Ryckman KK, Oltman SP, Rand L, Jelliffe-Pawlowski LL. PMID: 30549407.
      View in: PubMed   Mentions:
    32. Second trimester inflammatory and metabolic markers in women delivering preterm with and without preeclampsia. J Perinatol. 2019 02; 39(2):314-320. Ross KM, Baer RJ, Ryckman K, Feuer SK, Bandoli G, Chambers C, Flowers E, Liang L, Oltman S, Dunkel Schetter C, Jelliffe-Pawlowski L. PMID: 30518800.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Socioeconomic Mediators of Racial and Ethnic Disparities in Congenital Heart Disease Outcomes: A Population-Based Study in California. J Am Heart Assoc. 2018 10 16; 7(20):e010342. Peyvandi S, Baer RJ, Moon-Grady AJ, Oltman SP, Chambers CD, Norton ME, Rajagopal S, Ryckman KK, Jelliffe-Pawlowski LL, Steurer MA. PMID: 30371284.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    34. Implications of Changes in U.S. Food and Drug Administration Prescribing Information Regarding the Safety and Use of Asthma Biologics during Pregnancy. Ann Am Thorac Soc. 2018 10; 15(10):1131-1136. Schatz M, Krishnan JA, Chambers C. PMID: 30130420.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Effect of Fetal Growth on 1-Year Mortality in Neonates With Critical Congenital Heart Disease. J Am Heart Assoc. 2018 09 04; 7(17):e009693. Steurer MA, Baer RJ, Burke E, Peyvandi S, Oltman S, Chambers CD, Norton ME, Rand L, Rajagopal S, Ryckman KK, Feuer SK, Liang L, Paynter RA, McCarthy M, Moon-Grady AJ, Keller RL, Jelliffe-Pawlowski LL. PMID: 30371167.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. Risk of preterm birth by maternal age at first and second pregnancy and race/ethnicity. J Perinat Med. 2018 Jul 26; 46(5):539-546. Baer RJ, Yang J, Berghella V, Chambers CD, Coker TR, Kuppermann M, Oltman SP, Rand L, Ryckman KK, Muglia LJ, Chung PJ, Jelliffe-Pawlowski LL. PMID: 28455952.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices. Rheumatology (Oxford). 2018 07 01; 57(suppl_5):v9-v17. Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E, Sammaritano LR, Chambers CD, Buyon J. PMID: 30137589.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    38. Five successful pregnancies with antenatal anakinra exposure. Rheumatology (Oxford). 2018 Jul 01; 57(7):1271-1275. Smith CJF, Chambers CD. PMID: 29660063.
      View in: PubMed   Mentions: 4     Fields:    
    39. Approach to evaluating pregnancy safety of anti-rheumatic medications in the OTIS MotherToBaby pregnancy studies: what have we learned? Rheumatology (Oxford). 2018 07 01; 57(suppl_5):v34-v39. Chambers C, Johnson DL, Kiernan E. PMID: 30137588.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    40. Subclinical and clinical chorioamnionitis, fetal vasculitis, and risk for preterm birth: A cohort study. Placenta. 2018 07; 67:54-60. Palmsten K, Nelson KK, Laurent LC, Park S, Chambers CD, Parast MM. PMID: 29941174.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. Second trimester serum cortisol and preterm birth: an analysis by timing and subtype. J Perinatol. 2018 08; 38(8):973-981. Bandoli G, Jelliffe-Pawlowski LL, Feuer SK, Liang L, Oltman SP, Paynter R, Ross KM, Schetter CD, Ryckman KK, Chambers CD. PMID: 29795321.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Altered maternal immune networks are associated with adverse child neurodevelopment: Impact of alcohol consumption during pregnancy. Brain Behav Immun. 2018 10; 73:205-215. Bodnar TS, Raineki C, Wertelecki W, Yevtushok L, Plotka L, Zymak-Zakutnya N, Honerkamp-Smith G, Wells A, Rolland M, Woodward TS, Coles CD, Kable JA, Chambers CD, Weinberg J. PMID: 29738852.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    43. Prevalence of Fetal Alcohol Spectrum Disorders in 4 US Communities. JAMA. 2018 02 06; 319(5):474-482. May PA, Chambers CD, Kalberg WO, Zellner J, Feldman H, Buckley D, Kopald D, Hasken JM, Xu R, Honerkamp-Smith G, Taras H, Manning MA, Robinson LK, Adam MP, Abdul-Rahman O, Vaux K, Jewett T, Elliott AJ, Kable JA, Akshoomoff N, Falk D, Arroyo JA, Hereld D, Riley EP, Charness ME, Coles CD, Warren KR, Jones KL, Hoyme HE. PMID: 29411031.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    44. Risk of infantile hemangiomas in the offspring of women with autoimmune disease and the pathogenic implications of these lesions. . 2018 03; 176(3):570-577. Smith CJF, Jones KL, Johnson DL, Bandoli G, Robinson LK, Kavanaugh A, Chambers CD. PMID: 29341431.
      View in: PubMed   Mentions:
    45. Longitudinal trajectories of antidepressant use in pregnancy and the postnatal period. Arch Womens Ment Health. 2018 08; 21(4):411-419. Bandoli G, Kuo GM, Sugathan R, Chambers CD, Rolland M, Palmsten K. PMID: 29340802.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    46. Tailoring an Alcohol Intervention for American Indian Alaska Native Women of Childbearing Age: Listening to the Community. Alcohol Clin Exp Res. 2017 Nov; 41(11):1938-1945. Montag AC, Dusek ML, Ortega ML, Camp-Mazzetti A, Calac DJ, Chambers CD. PMID: 28833270.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    47. Commentary on: "Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12". Vaccine. 2017 09 25; 35(40):5323-5324. Chambers CD, Xu R, Mitchell AA. PMID: 28917296.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Factors associated with continued participation in a matched monetary incentive programme at local farmers' markets in low-income neighbourhoods in San Diego, California. Public Health Nutr. 2017 Oct; 20(15):2786-2795. Ratigan AR, Lindsay S, Lemus H, Chambers CD, Anderson CA, Cronan TA, Browner DK, Wooten WJ. PMID: 28756784.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    49. Chlamydia trachomatis Is Responsible for Lipid Vacuolation in the Amniotic Epithelium of Fetal Gastroschisis. Birth Defects Res. 2017 Jul 17; 109(13):1003-1010. Feldkamp ML, Ward DM, Pysher TJ, Chambers CT. PMID: 28635162.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    50. Community BMI Surveillance Using an Existing Immunization Registry in San Diego, California. J Community Health. 2017 Jun; 42(3):558-564. Ratigan AR, Lindsay S, Lemus H, Chambers CD, Anderson CAM, Cronan TA, Browner DK, Wooten WJ. PMID: 27837356.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    51. Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment. Birth Defects Res. 2017 Jul 03; 109(11):809-815. Smith CJF, Friedlander SF, Guma M, Kavanaugh A, Chambers CD. PMID: 28402073.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    52. Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children. J Pediatr. 2017 08; 187:141-146.e1. Newton KP, Feldman HS, Chambers CD, Wilson L, Behling C, Clark JM, Molleston JP, Chalasani N, Sanyal AJ, Fishbein MH, Lavine JE, Schwimmer JB. PMID: 28366357.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    53. The association of maternal lymphatic markers and critical congenital heart defects in the fetus-A population based case-control study. . 2017 May; 173(5):1231-1236. Steurer MA, Norton ME, Baer RJ, Shaw GM, Keating S, Moon-Grady AJ, Chambers CD, Jelliffe-Pawlowski LL. PMID: 28323386.
      View in: PubMed   Mentions:
    54. Plasma miRNA Profiles in Pregnant Women Predict Infant Outcomes following Prenatal Alcohol Exposure. PLoS One. 2016; 11(11):e0165081. Balaraman S, Schafer JJ, Tseng AM, Wertelecki W, Yevtushok L, Zymak-Zakutnya N, Chambers CD, Miranda RC. PMID: 27828986.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    55. Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease. Gastroenterology. 2017 02; 152(2):451-462.e2. Mahadevan U, McConnell RA, Chambers CD. PMID: 27769809.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    56. Critical congenital heart defects and abnormal levels of routinely collected first- and second-trimester biomarkers. . 2017 Feb; 173(2):368-374. Borelli M, Baer RJ, Chambers CD, Smith TC, Jelliffe-Pawlowski LL. PMID: 27739239.
      View in: PubMed   Mentions:
    57. Second-Trimester Ultrasound as a Tool for Early Detection of Fetal Alcohol Spectrum Disorders. Alcohol Clin Exp Res. 2016 11; 40(11):2418-2425. Montag AC, Hull AD, Yevtushok L, Zymak-Zakutnya N, Sosyniuk Z, Dolhov V, Jones KL, Wertelecki W, Chambers CD. PMID: 27688069.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    58. Cardiac Orienting Responses Differentiate the Impact of Prenatal Alcohol Exposure in Ukrainian Toddlers. Alcohol Clin Exp Res. 2016 11; 40(11):2377-2384. Kable JA, Coles CD, Jones KL, Yevtushok L, Kulikovsky Y, Wertelecki W, Chambers CD. PMID: 27650880.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Recurrence of Preterm Birth and Early Term Birth. Obstet Gynecol. 2016 08; 128(2):364-72. Yang J, Baer RJ, Berghella V, Chambers C, Chung P, Coker T, Currier RJ, Druzin ML, Kuppermann M, Muglia LJ, Norton ME, Rand L, Ryckman K, Shaw GM, Stevenson D, Jelliffe-Pawlowski LL. PMID: 27400000.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    60. Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS. Vaccine. 2016 08 17; 34(37):4443-9. Chambers CD, Johnson DL, Xu R, Luo YJ, Louik C, Mitchell AA, Schatz M, Jones KL. PMID: 27449682.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    61. Risk of preterm birth by subtype among Medi-Cal participants with mental illness. Am J Obstet Gynecol. 2016 10; 215(4):519.e1-9. Baer RJ, Chambers CD, Bandoli G, Jelliffe-Pawlowski LL. PMID: 27329688.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    62. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016 May; 75(5):795-810. Götestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, da Silva J, Nelson-Piercy C, Cetin I, Costedoat-Chalumeau N, Dolhain R, Förger F, Khamashta M, Ruiz-Irastorza G, Zink A, Vencovsky J, Cutolo M, Caeyers N, Zumbühl C, Østensen M. PMID: 26888948.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    63. Field studies versus database studies on the risks and benefits of medication use during pregnancy: Distinct pieces of the same puzzle. Reprod Toxicol. 2016 04; 60:123-8. Bérard A, Wisner KL, Hultzsch S, Chambers C. PMID: 26876485.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. Over-the-counter medications: Risk and safety in pregnancy. Semin Perinatol. 2015 Nov; 39(7):541-4. Chambers C. PMID: 26452317.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    65. Fetal alcohol spectrum disorders: Clinical phenotype among a high-risk group of children and adolescents in Korea. . 2016 Jan; 170A(1):19-23. Lee HS, Jones KL, Lee HK, Chambers CD. PMID: 26384109.
      View in: PubMed   Mentions:
    66. Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Vaccine. 2015 Nov 27; 33(48):6884-91. Baril L, Rosillon D, Willame C, Angelo MG, Zima J, van den Bosch JH, Van Staa T, Boggon R, Bunge EM, Hernandez-Diaz S, Chambers CD. PMID: 26206268.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    67. Accessibility of Catering Service Venues and Adolescent Drinking in Beijing, China. Int J Environ Res Public Health. 2015 Jun 26; 12(7):7208-19. Lu S, Du S, Ren Z, Zhao J, Chambers C, Wang J, Ma G. PMID: 26132475.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Immunization surveillance systems for pregnant women. Pharmacoepidemiol Drug Saf. 2015 Jun; 24(6):669. Mitchell AA, Louik C, Chambers C, Jones KL, Schatz M. PMID: 26053022.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    69. Maternal factors associated with the occurrence of gastroschisis. . 2015 Jul; 167(7):1534-41. Baer RJ, Chambers CD, Jones KL, Shew SB, MacKenzie TC, Shaw GM, Jelliffe-Pawlowski LL. PMID: 25913847.
      View in: PubMed   Mentions:
    70. Disease Severity and Pregnancy Outcomes in Women with Rheumatoid Arthritis: Results from the Organization of Teratology Information Specialists Autoimmune Diseases in Pregnancy Project. J Rheumatol. 2015 Aug; 42(8):1376-82. Bharti B, Lee SJ, Lindsay SP, Wingard DL, Jones KL, Lemus H, Chambers CD. PMID: 25877497.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    71. Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases. Arthritis Care Res (Hoboken). 2015 Mar; 67(3):313-25. Kavanaugh A, Cush JJ, Ahmed MS, Bermas BL, Chakravarty E, Chambers C, Clowse M, Curtis JR, Dao K, Hankins GD, Koren G, Kim SC, Lapteva L, Mahadevan U, Moore T, Nolan M, Ren Z, Sammaritano LR, Seymour S, Weisman MH. PMID: 25385050.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    72. State of the art: Reproduction and pregnancy in rheumatic diseases. Autoimmun Rev. 2015 May; 14(5):376-86. Østensen M, Andreoli L, Brucato A, Cetin I, Chambers C, Clowse ME, Costedoat-Chalumeau N, Cutolo M, Dolhain R, Fenstad MH, Förger F, Wahren-Herlenius M, Ruiz-Irastorza G, Koksvik H, Nelson-Piercy C, Shoenfeld Y, Tincani A, Villiger PM, Wallenius M, von Wolff M. PMID: 25555818.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    73. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine. 2013 Oct 17; 31(44):5026-32. Chambers CD, Johnson D, Xu R, Luo Y, Louik C, Mitchell AA, Schatz M, Jones KL. PMID: 24016809.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    74. Perceived neighborhood environment and physical activity in 11 countries: do associations differ by country? Int J Behav Nutr Phys Act. 2013 May 14; 10:57. Ding D, Adams MA, Sallis JF, Norman GJ, Hovell MF, Chambers CD, Hofstetter CR, Bowles HR, Hagströmer M, Craig CL, Gomez LF, De Bourdeaudhuij I, Macfarlane DJ, Ainsworth BE, Bergman P, Bull FC, Carr H, Klasson-Heggebo L, Inoue S, Murase N, Matsudo S, Matsudo V, McLean G, Sjöström M, Tomten H, Lefevre J, Volbekiene V, Bauman AE. PMID: 23672435.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    75. Creating a culturally appropriate web-based behavioral intervention for American Indian/Alaska Native women in Southern California: the healthy women healthy Native nation study. Am Indian Alsk Native Ment Health Res. 2013; 20(1):1-15. Gorman JR, Clapp JD, Calac D, Kolander C, Nyquist C, Chambers CD. PMID: 23529767.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    76. Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy. Birth Defects Res A Clin Mol Teratol. 2012 Aug; 94(8):607-11. Chambers CD, Johnson DL. PMID: 22786755.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    77. A sample size calculation for spontaneous abortion in observational studies. Reprod Toxicol. 2011 Dec; 32(4):490-3. Xu R, Chambers C. PMID: 21907789.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    78. The role of teratology information services in screening for teratogenic exposures: challenges and opportunities. Am J Med Genet C Semin Med Genet. 2011 Aug 15; 157C(3):195-200. Chambers C. PMID: 21748849.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    79. Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens. Congenit Anom (Kyoto). 2011 Mar; 51(1):16-20. Chambers CD. PMID: 21158951.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    80. Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum. 2010 May; 62(5):1494-503. Chambers CD, Johnson DL, Robinson LK, Braddock SR, Xu R, Lopez-Jimenez J, Mirrasoul N, Salas E, Luo YJ, Jin S, Jones KL. PMID: 20131283.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    81. Drug safety in pregnant women and their babies: ignorance not bliss. Clin Pharmacol Ther. 2008 Jan; 83(1):181-3. Chambers CD, Polifka JE, Friedman JM. PMID: 18073777.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    82. Novel risk factor in gastroschisis: change of paternity. . 2007 Apr 01; 143A(7):653-9. Chambers CD, Chen BH, Kalla K, Jernigan L, Jones KL. PMID: 17163540.
      View in: PubMed   Mentions:
    83. Accuracy of the diagnosis of physical features of fetal alcohol syndrome by pediatricians after specialized training. Pediatrics. 2006 Dec; 118(6):e1734-8. Jones KL, Robinson LK, Bakhireva LN, Marintcheva G, Storojev V, Strahova A, Sergeevskaya S, Budantseva S, Mattson SN, Riley EP, Chambers CD. PMID: 17088402.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    84. Risks of hyperthermia associated with hot tub or spa use by pregnant women. Birth Defects Res A Clin Mol Teratol. 2006 Aug; 76(8):569-73. Chambers CD. PMID: 16998815.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    85. Alcohol consumption patterns among pregnant women in the Moscow region of the Russian Federation. Alcohol. 2006 Apr; 38(3):133-7. Chambers CD, Kavteladze L, Joutchenko L, Bakhireva LN, Jones KL. PMID: 16905438.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    86. Intrauterine growth restriction in like-sex twins discordant for structural defects. Birth Defects Res A Clin Mol Teratol. 2006 Apr; 76(4):246-8. Chambers CD, Castilla EE, Orioli I, Jones KL. PMID: 16575884.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    87. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006 Feb 09; 354(6):579-87. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. PMID: 16467545.
      View in: PubMed   Mentions: 163     Fields:    Translation:Humans
    88. Safety of asthma and allergy medications in pregnancy. Immunol Allergy Clin North Am. 2006 Feb; 26(1):13-28. Chambers C. PMID: 16443141.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    89. Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther. 2006; 8(4):215. Chambers CD, Tutuncu ZN, Johnson D, Jones KL. PMID: 16774693.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    90. Postmarketing surveillance for drug safety in pregnancy: the Organization of Teratology Information Services project. Birth Defects Res A Clin Mol Teratol. 2004 Dec; 70(12):944-7. Felix RJ, Jones KL, Johnson KA, McCloskey CA, Chambers CD. PMID: 15570610.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    91. Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine. Teratology. 2002 Mar; 65(3):125-30. Jones KL, Johnson KA, Dick LM, Felix RJ, Kao KK, Chambers CD. PMID: 11877776.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    92. Postmarketing surveillance for human teratogenicity: a model approach. Teratology. 2001 Nov; 64(5):252-61. Chambers CD, Braddock SR, Briggs GG, Einarson A, Johnson YR, Miller RK, Polifka JE, Robinson LK, Stepanuk K, Lyons Jones K. PMID: 11745831.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    93. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics. 1999 Nov; 104(5):e61. Chambers CD, Anderson PO, Thomas RG, Dick LM, Felix RJ, Johnson KA, Jones KL. PMID: 10545587.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans